Efficacy and Safety of Topiramate in the Treatment of Sleep-Related Eating Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00606411

Recruitment Status : Completed

First Posted : February 4, 2008

Last Update Posted : August 14, 2019

View this study on Beta.ClinicalTrials.gov

Sponsor:

Information provided by (Responsible Party):

John Winkelman, MD, PhD, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	November 29, 2018
Actual Study Completion Date :	November 29, 2018

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Winkelman JW, Wipper B, Purks J, Mei L, Schoerning L. Topiramate reduces nocturnal eating in sleep-related eating disorder. Sleep. 2020 Sep 14;43(9):zsaa060. doi: 10.1093/sleep/zsaa060.

To Top